Aspire Biopharma Holdings, Inc. Common Stock

ASBP XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

7.8M

Short interest (May 15)

6.3%

Net Short (Jun 03 ): 0.1%

Borrow Fee

144.41%

↑ 19.6%

Available Shares

40K

↑ 78.5%

Price Chart

Company Overview

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001847345

Asset Type: CS

Market Data

Market Cap: $7,797,308

Status: Active

Short Interest

Current Borrow Fee 144.41%

Range: 144.41% - 190.44%

Available Shares 40K

Range: 1K - 40K

Recent Changes

Fee Change: ↑ 2.9%

Available Change: ↑ 485.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime